Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Oryzon Genomics SA
F:ORN
Oryzon Genomics SA
F:ORN
Price:
2.538
EUR
0.87%
Market Closed
Market Cap:
€159.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Oryzon Genomics SA
F:ORN
|
ES |
|
Oaktree Specialty Lending Corp
F:FFC0
|
US |
|
CD Projekt SA
F:7CD
|
PL |
|
Swiss Water Decaffeinated Coffee Inc
TSX:SWP
|
CA |
|
Autoneum Holding AG
OTC:ATNNF
|
CH |
|
Jinli Group Holdings Ltd
TWSE:8429
|
KY |
Wall St Price Targets
ORN Price Forecast
Based on 10 analysts
Based on 10 analysts
+193% Upside
from
€2.538
today
Oryzon Genomics SA (ORN)’s 12-month stock price forecast through October 2027 has a consensus target of €7.444, implying 193% upside. The forecast is based on price targets from 10 Wall Street analysts.
ORN Analyst Rating
No ratings yet
No ratings yet
Oryzon Genomics SA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ORN's stock price target?
Price Target
7.444
EUR
7.444
EUR
According to Wall Street analysts, the average 1-year price target for ORN is 7.444 EUR with a low forecast of 5.16 EUR and a high forecast of 15.326 EUR.